CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents, $89 reserved at September 30, 2014	$ 3,111	$ 6,258
Other current assets	277	233
Total current assets	3,388	6,491
Patent license rights, net	705	823
Furniture and equipment, net	0	3
Total assets	4,093	7,317
Current liabilities
Accounts payable	225	88
Other accrued liabilities	246	12
Total current liabilities	471	100
Capstone Therapeutics Corp. Stockholders' Equity
Common Stock $.0005 par value; 100,000,000 shares authorized;40,885,411 shares in 2014 and 2013 issued and outstanding	20	20
Additional paid-in capital	189,267	189,215
Accumulated deficit	(185,665)	(182,018)
Total Capstone Therapeutics Corp. stockholders' equity	3,622	7,217
Noncontrolling interest	0	0
Total equity	3,622	7,217
Total liabilities and equity	$ 4,093	$ 7,317